<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Ekologiya cheloveka (Human Ecology)</journal-id><journal-title-group><journal-title xml:lang="en">Ekologiya cheloveka (Human Ecology)</journal-title><trans-title-group xml:lang="ru"><trans-title>Экология человека</trans-title></trans-title-group></journal-title-group><issn publication-format="print">1728-0869</issn><issn publication-format="electronic">2949-1444</issn><publisher><publisher-name xml:lang="en">Eco-Vector</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">79455</article-id><article-id pub-id-type="doi">10.33396/1728-0869-2021-8-57-64</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>Articles</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>Статьи</subject></subj-group><subj-group subj-group-type="article-type"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title xml:lang="en">Public Health Rehabilition after Acute Myocardial Infarction: a Randomized Controlled Study</article-title><trans-title-group xml:lang="ru"><trans-title>АМБУЛАТОРНАЯ РЕАБИЛИТАЦИЯ ПОСЛЕ ОСТРОГО ИНФАРКТА МИОКАРДА: РАНДОМИЗИРОВАННОЕ КОНТРОЛИРУЕМОЕ ИСПЫТАНИЕ</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Zhamankulova</surname><given-names>Damira G.</given-names></name><name xml:lang="ru"><surname>Жаманкулова</surname><given-names>Д. Г.</given-names></name></name-alternatives><bio xml:lang="en"><p>PhD student</p></bio><email>bianconeri-98@mail.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Zhamaliyeva</surname><given-names>Lazzat M.</given-names></name><name xml:lang="ru"><surname>Жамалиева</surname><given-names>Л. М.</given-names></name></name-alternatives><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Kurmanalina</surname><given-names>Gulnara L.</given-names></name><name xml:lang="ru"><surname>Курманалина</surname><given-names>Г. Л.</given-names></name></name-alternatives><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Tanbetova</surname><given-names>Ziyash</given-names></name><name xml:lang="ru"><surname>Танбетова</surname><given-names>З.</given-names></name></name-alternatives><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Grjibovski</surname><given-names>Andrey M.</given-names></name><name xml:lang="ru"><surname>Гржибовский</surname><given-names>А. М.</given-names></name></name-alternatives><xref ref-type="aff" rid="aff1"/><xref ref-type="aff" rid="aff2"/><xref ref-type="aff" rid="aff3"/><xref ref-type="aff" rid="aff4"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">West Kazakhstan Marat Ospanov Medical University</institution></aff><aff><institution xml:lang="ru">Западно-Казахстанский медицинский университет имени Марата Оспанова</institution></aff></aff-alternatives><aff-alternatives id="aff2"><aff><institution xml:lang="en">Northern State Medical University</institution></aff><aff><institution xml:lang="ru">Северный государственный медицинский университет</institution></aff></aff-alternatives><aff-alternatives id="aff3"><aff><institution xml:lang="en">North-Eastern Federal University</institution></aff><aff><institution xml:lang="ru">Северо-Восточный федеральный университет имени М. К. Аммосова</institution></aff></aff-alternatives><aff-alternatives id="aff4"><aff><institution xml:lang="en">Al-Farabi Kazakh National University</institution></aff><aff><institution xml:lang="ru">Казахский национальный университет имени Аль-Фараби</institution></aff></aff-alternatives><pub-date date-type="pub" iso-8601-date="2021-08-15" publication-format="electronic"><day>15</day><month>08</month><year>2021</year></pub-date><volume>28</volume><issue>8</issue><issue-title xml:lang="en">NO8 (2021)</issue-title><issue-title xml:lang="ru">№8 (2021)</issue-title><fpage>57</fpage><lpage>64</lpage><history><date date-type="received" iso-8601-date="2021-09-02"><day>02</day><month>09</month><year>2021</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2021, Zhamankulova D.G., Zhamaliyeva L.M., Kurmanalina G.L., Tanbetova Z., Grjibovski A.M.</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2021, Жаманкулова Д.Г., Жамалиева Л.М., Курманалина Г.Л., Танбетова З., Гржибовский А.М.</copyright-statement><copyright-year>2021</copyright-year><copyright-holder xml:lang="en">Zhamankulova D.G., Zhamaliyeva L.M., Kurmanalina G.L., Tanbetova Z., Grjibovski A.M.</copyright-holder><copyright-holder xml:lang="ru">Жаманкулова Д.Г., Жамалиева Л.М., Курманалина Г.Л., Танбетова З., Гржибовский А.М.</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/"/><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/">https://creativecommons.org/licenses/by-nc-nd/4.0</ali:license_ref></license></permissions><self-uri xlink:href="https://hum-ecol.ru/1728-0869/article/view/79455">https://hum-ecol.ru/1728-0869/article/view/79455</self-uri><abstract xml:lang="en"><p>Background: Cardiovascular diseases (CVD) are the main causes of death worldwide. The incidence of and mortality from CVD in Kazakhstan is greater than in most neighboring countries warranting urgent public health measures related to both primary, secondary and tertiary prevention. Aims: To assess whether a newly developed 6-months public health rehabilitation program for patients with acute myocardial infarction (AMI) with home visits performed by physician assistants is superior to the standard rehabilitation of these patients in Western Kazakhstan. Methods: A randomized controlled study. A total of 75 AMI patients were enrolled after discharge form the hospital and 72 completed the trial. The control group (n = 34) participated in the standard rehabilitation program while the intervention group (n = 38) underwent and experimental rehabilitation program with home visits in addition to the standard program. Body mass index, waist circumference, blood pressure, heart rate, blood lipids, smoking and compliance to the treatment were assessed at the enrollment and after 6 months of the follow-up. Differences between the changes in the intervention and in the control group were compared using Mann-Whitney tests. Results: The experimental program was superior to the standard program in reducing systolic- (-22.5 vs. -2.9 mm Hg, p &lt; 0.004) and diastolic (-6.3 vs. -0.6 mm Hg, p = 0.032) blood pressure, body mass index (-0.99 vs. 0.53 kg/m2, p &lt; 0.001), waist circumference (-3.0 vs. 1.7 cm, p &lt; 0.001) and the number of smoked cigarettes (-12 vs. -3, p = 0.002). Blood lipid profiles improved in both groups. Although slightly more pronounced changes were observed in the intervention group, the differences did not reach the level of statistical significance. Conclusions: The program was more effective on blood pressure, smoking and obesity-related indicators than the standard rehabilitation. Larger studies are warranted to corroborate our findings prior to implementation of the program in practice.</p></abstract><trans-abstract xml:lang="ru"><p>Актуальность: Сердечно-сосудистые заболевания (ССЗ) являются основными причинами смерти во всем мире. Заболеваемость и смертность по причине ССЗ в Казахстане выше, чем в большинстве соседних стран, что требует неотложных мер общественного здравоохранения, связанных как с первичной, вторичной, так и с третичной профилактикой. Цели: Оценить, превосходит ли недавно разработанная 6-месячная программа реабилитации пациентов с острым инфарктом миокарда (ОИМ) на дому с помощью врачей стандартную реабилитацию пациентов с ОИМ в Западном Казахстане. Методы: В рандомизированное контролируемое исследование были включены 75 пациентов с ОИМ после выписки из больницы, и 72 пациента завершили исследование. Контрольная группа (n = 34) участвовала в стандартной программе реабилитации, группа вмешательства (n = 38) прошла экспериментальную программу реабилитации с посещениями на дому в дополнение к стандартной программе. Индекс массы тела, окружность талии, артериальное давление, частота сердечных сокращений, липиды крови, курение и соблюдение режима лечения оценивались при включении и через 6 месяцев наблюдения. Различия между изменениями в группе вмешательства и в контрольной группе сравнивали с помощью тестов Манна - Уитни. Результаты: Экспериментальная программа превосходила стандартную по снижению систолического (-22,5 против -2,9 мм рт. ст., p &lt; 0,004) и диастолического (-6,3 против -0,6 мм рт. ст., p = 0.032) артериального давления, индекса массы тела (-0,99 против 0,53 кг/м2, p &lt; 0,001), окружности талии (-3,0 против 1,7 см, p &lt; 0,001) и количеству курящих (-12 против -3, p = 0,002). Липидный профиль крови улучшился в обеих группах. Хотя в группе вмешательства наблюдались несколько более выраженные изменения, различия не достигли уровня статистической значимости. Выводы: Программа оказалась более эффективной по показателям артериального давления, курения и ожирения, чем стандартная реабилитация. Необходимы более масштабные исследования для подтверждения наших выводов до реализации программы на практике.</p></trans-abstract><kwd-group xml:lang="en"><kwd>acute myocardial infarction</kwd><kwd>rehabilitation</kwd><kwd>primary care</kwd><kwd>Kazakhstan</kwd><kwd>physician assistants</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>острый инфаркт миокарда</kwd><kwd>реабилитация</kwd><kwd>первичная помощь</kwd><kwd>Казахстан</kwd><kwd>помощники врачей</kwd></kwd-group></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>Ахмеджанов Н. М., Небиеридзе Д. В., Сафарян А. С., Выгодин В. А., Шураев А. Ю., Ткачева О. Н., Лишута А. С. Анализ распространенности гиперхолестеринемии в условиях амбулаторной практики (по данным исследования АРГО): часть I // Рациональная фармакотерапия в кардиологии. 2015. № 11 (3). С. 253-260</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>Бойцов С. А., Баланова Ю. А., Шальнова С. А. и др. Артериальная гипертония среди лиц 25-64 лет: распространенность, осведомленность, лечение и контроль. По материалам исследования ЭССЕ // Кардиоваскулярная терапия и профилактика. 2014. № 14 (4). C. 4-14</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>Европейские рекомендации по профилактике сердечно-сосудистых заболеваний в клинической практике (Пересмотр 2016) // Российский кардиологический журнал. 2017. Т. 6 (146). С. 7-85</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>Недогода С. В., Сабанов А. В. Достижение целевого артериального давления у пациентов с артериальной гипертензией на фоне антигипертензивной терапии в условиях реальной клинической практики // Российский кардиологический журнал. 2018. Т. 23 (11). С. 100-109</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>Рекомендации ЕОК/ЕОА по лечению дислипидемий // Рациональная фармакотерапия в кардиологии. 2012. Прил. № 1. С. 3-63</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>Садыкова А. Д., Смаилова А. A., Шалапов Д. М., Саттиева С. К., Ауелбекова А. А. Эпидемиология основных фатальных осложнений сердечно-сосудистых заболеваний (обзор литературы) // Медицина (Алматы). 2017. № 11 (185). С. 61-66. [In Russian]</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation>Tolpygina S. N., Polyanskaya Yu. N., Martsevich S. Yu. Hypolipidemic Therapy in Patients with Chronic Ischemic Heart Disease in 2004-2010 According to the Prognoz IBS Register. Ratsional'naya farmakoterapiya v kardiologii [Rational Pharmacotherapy in Cardiology]. 2015, 11 (2), pp. 153-158. [In Russian]</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation>Akyea RK, Kai J, Qureshi N, Iyen B, Weng SF. Suboptimal cholesterol response to initiation of statins and future risk of cardiovascular disease. Heart. 2019, 105 (13), pp. 975-981.</mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation>Allen JK, Dennison CR. Randomized trials of nursing interventions for secondary prevention in patients with coronary artery disease and heart failure: systematic review. J Cardiovasc Nurs. 2010 May-Jun, 25 (3), pp. 207-20. DOI: 10.1097/ JCN.0b013e3181cc79be. PMID: 20386243.</mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation>Aringazina A, Kuandikov T, Arkhipov V. Burden of the Cardiovascular Diseases in Central Asia. Cent Asian J Glob Health. 2018, 7 (1), p. 321.</mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation>Borghi C, Tubach F, De Backer G et al. Lack of control of hypertension in primary cardiovascular disease prevention in Europe Results from the EURIKA study. Int J Cardiol. 2016, 218, pp. 83-88.</mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation>Bruinooge SS, Pickard TA, Vogel W et al. Understanding the role of advanced practice providers in oncology in the United States. JAAPA. 2018, 31 (12), pp. 1-12.</mixed-citation></ref><ref id="B13"><label>13.</label><mixed-citation>Chow CK, Jolly S, Rao-Melacini P, Fox KAA, Anand SS, Yusuf S. Association of diet, exercise, and smoking modification with risk of early cardiovascular events after acute coronary syndromes. Circulation. 2010, 121 (6), pp. 750-8.</mixed-citation></ref><ref id="B14"><label>14.</label><mixed-citation>Clark H. NCDs. А challenge to sustainable human development. Lancet. 2013, 381, pp. 510-511.</mixed-citation></ref><ref id="B15"><label>15.</label><mixed-citation>Czernichow S, Kengne AP, Stamatakis E, Hamer M, Batty GD. Body mass index, waist circumference and waist-hip ratio: which is the better discriminator of cardiovascular disease mortality risk?: evidence from an individual-participant meta-analysis of 82 864 participants from nine cohort studies. Obes Rev. 2011, 12 (9), pp. 680-687.</mixed-citation></ref><ref id="B16"><label>16.</label><mixed-citation>Altman D, Schulz KF, Moher D et al. The Revised CONSORT Statement for Reporting Randomized Trials: Explanation and Elaboration. Academia and the Profession: 17 April 2001.</mixed-citation></ref><ref id="B17"><label>17.</label><mixed-citation>Finegold JA, Asaria P, Francis DP. Mortality from ischaemic heart disease by country, region, and age: statistics from World Health Organisation and United Nations. Int J Cardiol. 2013, 168 (2), pp. 934-45.</mixed-citation></ref><ref id="B18"><label>18.</label><mixed-citation>Garvey C, Ortiz G. Exacerbations of chronic obstructive pulmonary disease. Open Nurs J. 2012, 6, pp. 13-19.</mixed-citation></ref><ref id="B19"><label>19.</label><mixed-citation>Jayaraj JC, Davatyan K, Submanian SS Priya J. Epidemiology of Myocardial Infarction. DOI: 10.5772/ intechopen.74768.</mixed-citation></ref><ref id="B20"><label>20.</label><mixed-citation>Jorstad HT, von Birgelen C, Alings AM, et al. Effect of a nurse-coordinated prevention programme on cardiovascular risk after an acute coronary syndrome: main results of the RESPONSE randomised trial. Heart. 2013, 99 (19), pp. 1421-1430.</mixed-citation></ref><ref id="B21"><label>21.</label><mixed-citation>Kashkinbayeva AR, Tanbetova ZZh, Zhamaliyeva LM, Zame YA, Zhamankulova DG. Motivational interview skills teaching in the training of PHC assistants in WKMU. West Kazakhstan Medical Journal. 2020, 62 (1), pp. 25-31.</mixed-citation></ref><ref id="B22"><label>22.</label><mixed-citation>Khan MAB, Hashim MJ, Mustafa H. et all. Global Epidemiology of Ischemic Heart Disease: Results from the Global Burden of Disease Study. Cureus. 2020 Jul 23, 12 (7), e9349.</mixed-citation></ref><ref id="B23"><label>23.</label><mixed-citation>Kim C, Choi I, Cho S, Kim AR, Kim W, Jee S. Do Cardiac Rehabilitation Affect Clinical Prognoses Such as Recurrence, Readmission, Revascularization, and Mortality After AMI?: Systematic Review and Meta-Analysis. Ann Rehabil Med. 2021 Feb, 45 (1), pp. 57-70.</mixed-citation></ref><ref id="B24"><label>24.</label><mixed-citation>Kotseva K, De Backer G, De Bacquer D, et al. Lifestyle and impact on cardiovascular risk factor control in coronary patients across 27 countries: Results from the European Society of Cardiology ESC-EORP EUROASPIRE V registry. Eur J Prev Cardiol. 2019, 26 (8), pp. 824-835.</mixed-citation></ref><ref id="B25"><label>25.</label><mixed-citation>Lawler PR, Filion KB, Eisenberg MJ. Efficacy of exercise-based cardiac rehabilitation post-myocardial infarction: A systematic review and meta-analysis of randomized controlled trials. American Heart Journal. 2011, 162 (4), pp. 571-584, e2.</mixed-citation></ref><ref id="B26"><label>26.</label><mixed-citation>Management of dyslipidaemia in patients with coronary heart disease:Results from the ESC-EORP EUROASPIRE V survey in 27 countries. Atherosclerosis. 2019, 285, pp. 135-146.</mixed-citation></ref><ref id="B27"><label>27.</label><mixed-citation>McMahon SR, Ades PA, Thompson PD. The role of cardiac rehabilitation in patients with heart disease. Trends Cardiovasc Med. 2017, 27 (6), pp. 420-425.</mixed-citation></ref><ref id="B28"><label>28.</label><mixed-citation>Nowbar AN, Gitto M, Howard JP, Francis DP, Al-Lamee R. Mortality from Ischemic Heart Disease. Circ Cardiovasc Qual Outcomes. 2019, 12 (6), e005375.</mixed-citation></ref><ref id="B29"><label>29.</label><mixed-citation>Piepoli MF. 2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts). Int J Behav Med. 2017 Jun, 24 (3), pp. 321-419.</mixed-citation></ref><ref id="B30"><label>30.</label><mixed-citation>Pivina LM, Moldagalieva ZhT, Muzdubayeva ZhE, Belikhina TI, Markabayeva AM, Zhunussova TT. Medical and social problem of cardiovascular diseases in Kazakhstan. Science &amp; Healthcare. 2015, 2.</mixed-citation></ref><ref id="B31"><label>31.</label><mixed-citation>Roth GA, Johnson C, Abajobir A, et al. Global, Regional, and National Burden of Cardiovascular Diseases for 10 Causes, 1990 to 2015. J Am Coll Cardiol. 2017, 70 (1), pp. 1-25.</mixed-citation></ref><ref id="B32"><label>32.</label><mixed-citation>Soo Hoo SY, Gallagher R, Elliott D. Predictors of cardiac rehabilitation attendance following primary percutaneous coronary intervention for ST-elevation myocardial infarction in Australia. Nurs Health Sci. 2016, 18 (2), pp. 230-7.</mixed-citation></ref><ref id="B33"><label>33.</label><mixed-citation>Virani SS, Maddox TM, Chan PS et al. Provider Type and Quality of Outpatient Cardiovascular Disease Care: Insights From the NCDR PINNACLE Registry. J Am Coll Cardiol. 2015, 66 (16), pp. 1803-1812.</mixed-citation></ref><ref id="B34"><label>34.</label><mixed-citation>Urbinati S, Tonet E. Cardiac rehabilitation after STEMI. Minerva Cardioangiol. 2018, 66 (4), pp. 464-470.</mixed-citation></ref><ref id="B35"><label>35.</label><mixed-citation>2018 ESC/ESH Guidelines for the Management of Arterial Hypertension. Eur Heart J. 2018, 40 (25), p. 2092.</mixed-citation></ref></ref-list></back></article>
